Virtual Data Room Resources | ShareVault

12 Articles

Finance × Fundraising × Negotiation × Other Topics × methodology ×

Best Practices for Fundraising and M&A Due Diligence

This whitepaper explores the importance of establishing early goals and objectives for the process, how to get the right people to ask the right questions in advance of the process, how to build credibility by defining goals and demonstrating they can be achieved, and much more.

Due Diligence Finance Fundraising Mergers & Acquisitions Whitepapers

Successful Biotech Licensing Negotiations

In this whitepaper, Linda Pullan provides licensing negotiations insights from a biotech business development perspective.

BioPharma Life Sciences Other Topics Whitepapers

Earnouts: Structures for Breaking Negotiation Deadlocks

This white paper features Senior M&A Executive Javier Enrile of Principal Global Investors. Mr. Enrile provides his extensive expertise to explain how earnout, (also "earn-out") structures work and how it can reduce risk for the buyer, add attractive incentives for the seller, and serve to break negotiation deadlocks and get deals consummated.

Finance Mergers & Acquisitions Negotiation Whitepapers

What's Hot and What's Not in Oncology Licensing in 2020?

In this whitepaper, Linda Pullan, PhD of Pullan Consulting and our panel of experts provided insights in oncology and immuno-oncology in 2020.

Best Practices & Trends BioPharma Life Sciences Other Topics Series Whitepapers

A Medical Device Manufacturer's Guide to Selecting Suppliers

This white paper covers when to consider using suppliers, key differences between standard / OTS and custom part suppliers, tools and methods for managing suppliers, and when and how to transition between suppliers and internal resources.

Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers

Preparing Your Company for the M&A Process

When it’s time to exit your business, being prepared and having a well-planned exit strategy can be the difference between a good transaction and a great one.

Best Practices & Trends Finance Mergers & Acquisitions Whitepapers

Practical Application of Artificial Intelligence in Drug Discovery and Development

In this whitepaper, learn what is artificial intelligence and how is it being applied to drug discovery, and much more.

Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers

How to Apply the Golden Rule of Research to your Trial Master File

This whitepaper evaluates the regulations that support GDP, best practices on how document contributors can apply the golden rule of research to their TMF, how to avoid writing too many and unnecessary Note-to-Files (NTFs), and tips on becoming inspection ready and staying that way.

Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers

Demystifying Tech M&A Valuation

In this whitepaper, explore the nuances of valuation, its framework and the processes for getting it right.

Best Practices & Trends Finance Mergers & Acquisitions Other Topics Valuation Whitepapers

Selling Your Healthcare or Life Sciences Company

This whitepaper gives medical groups, life sciences, and healthcare companies in the lower middle market an understanding of financing and M&A alternatives available, the role of financial buyers, key issues around selling equity in your business, and the typical financing and M&A process.

BioPharma Life Sciences Other Industries Other Topics Whitepapers

M&A Negotiations

This whitepaper shares the most common scenarios that arise when you are selling your company, the choices you have when negotiating the terms of the sale, and which choices are your best ones, as supported by academic research are covered.

Best Practices & Trends Life Sciences Mergers & Acquisitions Negotiation Whitepapers

Pullan's Pieces - A Business Development View of the Oncology Landscape

In this whitepaper, biopharma partnering expert and Life Sciences consultant, Linda Pullan, PhD, explores the current oncology landscape and offers insightful perspective on trends, pipeline by indication, dealmaking, and the top ten oncology companies and the drugs they’re developing.

Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers

1
2
3
4
5